Publication: Network meta-analysis on latanoprostene bunod and glaucoma
A network meta-analysis by our team focusing on the treatment of glaucoma: Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular…
News
Announcements, studies and events from PeriPharm – market access, health economics and real-world evidence.
Proud to Attend ISPOR Europe 2020 Virtual Conference!
PeriPharm is proud to attend and present some collaborations at the ISPOR 2020 virtual conference which will be held from November 16 to 19.
Publication: Real-world apremilast experience for psoriasis in Québec
Fresh from the press: a new publication presenting real-world evidence! Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis…
Network Meta-Analysis Brochure
Network meta-analysis (NMA) is used to estimate the relative effectiveness of all relevant interventions using rigorous statistical methods of quantitative assessment, even in the absence…
Claims Database Analyses Brochure
Claims database analyses can provide insight on pharmaceutical and medical services utilization associated with a specific diagnosis, disease or treatment in routine clinical practice.
In-Licensing Market Assessment Brochure
Looking for insight on quality candidates? PeriPharm can help companies seeking partnering and in-licensing opportunities by assessing a product’s potential performance on the Canadian market…
COVID-19 – Our Services are Maintainted
With the current situation, we recognize the importance of preventing the spread of COVID-19 while continuing to offer our services in pharmacoeconomics, outcomes research and…
Proud to be Sponsoring the 2020 CADTH Symposium!
PeriPharm is proud to sponsor the 2020 CADTH Symposium in Toronto, April 18 to 21.